Azab Mohammed A, O'Hagan Molly, Abou-Al-Shaar Hussam, Karsy Michael, Guan Jian, Couldwell William T
Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, USA.
Department of Neurosurgery, New York Medical College, Valhalla, New York, USA.
World Neurosurg. 2019 Feb;122:e1252-e1258. doi: 10.1016/j.wneu.2018.11.024. Epub 2018 Nov 14.
Pituitary adenomas account for 10%-20% of intracranial brain tumors but have greater incidence in elderly patients. We assessed microsurgical treatment for pituitary adenomas in this population.
A retrospective cohort of patients ≥60 years of age was identified. Patients were divided into deciles by age for evaluation of variables affecting outcome: 60-70 (group 1), 71-80 (group 2), and >80 years (group 3).
Two hundred five patients were identified among group 1 (n = 131), group 2 (n = 65), and group 3 (n = 9). Preoperative variables other than age did not differ. Most patients presented with visual disturbance, in 56.5%, 73.8%, and 50% in groups 1, 2, and 3, respectively. The next most common indication was headache, followed by endocrinopathy. Tumors were overwhelmingly nonfunctional (P = 0.97) and macroadenomas (P = 0.5) in all 3 groups. Gross total resection occurred in 56.9%-80% of patients, and this rate did not differ among groups. Complication rates of 6.9% in group 1, 9.2% in group 2, and 0.0% in group 3 were observed (P = 0.8). No perioperative mortality was identified. Mean length of follow-up ranged from 8.9 to 28.3 months.
In this series of microsurgical resection of pituitary adenomas in elderly patients, good efficacy and safety of treatment were observed. Preclusion of surgical treatment, including open resection, simply because of age is not warranted and instead a comprehensive evaluation of a patient's risk profile and surgical goals should be undertaken.
垂体腺瘤占颅内脑肿瘤的10%-20%,但在老年患者中发病率更高。我们评估了该人群垂体腺瘤的显微外科治疗。
确定了≥60岁患者的回顾性队列。按年龄将患者分为十分位数以评估影响预后的变量:60-70岁(第1组)、71-80岁(第2组)和>80岁(第3组)。
在第1组(n = 131)、第2组(n = 65)和第3组(n = 9)中确定了205例患者。除年龄外的术前变量无差异。大多数患者表现为视力障碍,第1组、第2组和第3组分别为56.5%、73.8%和50%。其次最常见的指征是头痛,其次是内分泌病。所有3组中的肿瘤绝大多数为无功能肿瘤(P = 0.97)和大腺瘤(P = 0.5)。56.9%-80%的患者实现了全切除,且该比例在各组之间无差异。观察到第1组的并发症发生率为6.9%,第2组为9.2%,第3组为0.0%(P = 0.8)。未发现围手术期死亡。平均随访时间为8.9至28.3个月。
在这一系列老年患者垂体腺瘤的显微外科切除中,观察到了良好的治疗效果和安全性。不应仅仅因为年龄而排除包括开放切除在内的手术治疗,而应全面评估患者的风险状况和手术目标。